For the quarter ending 2026-03-31, INSM made $305,964K in revenue. -$163,563K in net income. Net profit margin of -53.46%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Product revenues, net | 305,964 | 263,843 | 142,342 | 107,415 |
| Cost of product revenues (excluding amortization of intangible assets) | 47,420 | 44,220 | 29,365 | 28,075 |
| Research and development | 209,485 | 254,911 | 186,415 | 177,190 |
| Selling, general and administrative | 247,259 | 212,483 | 186,376 | 154,763 |
| Amortization of intangible assets | 2,081 | 1,937 | 1,538 | 1,263 |
| Change in fair value of contingent consideration | -46,961 | 70,040 | 104,653 | 59,000 |
| Total operating expenses | 459,284 | 583,591 | 508,347 | 420,291 |
| Operating loss | -153,320 | -319,748 | -366,005 | -312,876 |
| Investment income | 12,040 | 15,236 | 18,289 | 13,225 |
| Interest expense | 20,082 | 20,599 | 20,382 | 21,245 |
| Change in fair value of interest rate swap | - | 0 | 0 | 0 |
| Other (expense) income, net | -736 | -1,823 | -603 | 453 |
| Loss before income taxes | -162,098 | -326,934 | -368,701 | -320,443 |
| Provision for income taxes | 1,465 | 1,551 | 1,320 | 1,243 |
| Net loss | -163,563 | -328,485 | -370,021 | -321,686 |
| Basic EPS | -0.76 | -1.534 | -1.75 | -1.7 |
| Diluted EPS | -0.76 | -1.534 | -1.75 | -1.7 |
| Basic Average Shares | 215,468,000 | 214,135,000 | 211,759,000 | 189,302,000 |
| Diluted Average Shares | 215,468,000 | 214,135,000 | 211,759,000 | 189,302,000 |
INSMED Inc (INSM)
INSMED Inc (INSM)